NovelStem International Corp. (NSTM)
0.0106
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
NovelStem International Net Income (TTM) : -0.3076M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3076M |
| March 31, 2026 | 2.532M |
| December 31, 2025 | 2.380M |
| September 30, 2025 | 0.6775M |
| June 30, 2025 | -1.709M |
| March 31, 2025 | -4.766M |
| December 31, 2024 | -4.862M |
| September 30, 2024 | -3.053M |
| June 30, 2024 | -1.686M |
| March 31, 2024 | -4.258M |
| December 31, 2023 | -4.223M |
| September 30, 2023 | -4.516M |
| June 30, 2023 | -3.715M |
| March 31, 2023 | -2.467M |
| December 31, 2022 | 6.013M |
| September 30, 2022 | 6.246M |
| December 31, 2013 | 6.253M |
| September 30, 2013 | 12.69M |
| June 30, 2013 | 2.163M |
| March 31, 2013 | 0.8572M |
| December 31, 2012 | 0.5359M |
| September 30, 2012 | -4.450M |
| June 30, 2012 | -7.714M |
| March 31, 2012 | -6.198M |
| December 31, 2011 | -7.302M |
| Date | Value |
|---|---|
| September 30, 2011 | -8.386M |
| June 30, 2011 | -3.622M |
| March 31, 2011 | -3.744M |
| December 31, 2010 | -2.795M |
| September 30, 2010 | -2.095M |
| June 30, 2010 | -2.067M |
| March 31, 2010 | -6.909M |
| December 31, 2009 | -6.239M |
| September 30, 2009 | -11.95M |
| June 30, 2009 | -13.06M |
| March 31, 2009 | -8.958M |
| December 31, 2008 | -11.99M |
| September 30, 2008 | -7.895M |
| June 30, 2008 | -8.129M |
| March 31, 2008 | -8.889M |
| December 31, 2007 | -8.834M |
| September 30, 2007 | -7.850M |
| June 30, 2007 | -7.769M |
| March 31, 2007 | -7.528M |
| December 31, 2006 | -7.148M |
| September 30, 2006 | -7.334M |
| June 30, 2006 | -7.791M |
| March 31, 2006 | -8.464M |
| December 31, 2005 | -8.745M |
| September 30, 2005 | -11.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -10.52M |
| Summit Therapeutics, Inc. | -856.09M |
| Kezar Life Sciences, Inc. | -45.23M |
| Protara Therapeutics, Inc. | -70.02M |
| Clene, Inc. | -39.52M |